Neuro-computational Study of Thymic Fluctuations in Mood Disorders
Launched by CENTRE HOSPITALIER ST ANNE · Jun 13, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical study is exploring how mood changes in people with depression and bipolar disorder compared to those without these conditions. Researchers want to better understand the biological and brain-based reasons behind mood swings by combining brain scans with daily mood tracking using a smartphone app. The goal is to see if a short brain scan can help predict how someone’s mood and condition might change over time. The study also offers optional activities where participants can use apps to track emotions passively and record their voice, which may help identify unique mood or speech patterns related to these disorders.
People who may join include adults aged 18 to 74 who have been diagnosed with depression or bipolar disorder in the past year, as well as healthy volunteers without psychiatric conditions. Participants will first take part in a brain imaging session, then use a smartphone app daily for up to a year to report on their mood and make simple choices. This helps researchers understand mood changes in real life. The study is currently recruiting, and participants should be able to use a smartphone daily and not have any medical reasons that would prevent them from having an MRI scan.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Common between groups (DD, BD, control and GP):
- • Having given informed and written consent
- • Being covered by social security
- For patients with depressive disorder (DD):
- • Having been diagnosed with characterized depressive episode (F32, F33, F34) according to the ICD-10, by a psychiatrist, or having presented this diagnosis during the past 12 months
- For patients with bipolar disorder (BD):
- • Presenting a diagnosis of bipolar mood disorder (F31) according to ICD-10, by a psychiatrist
- • Having presented a mood episode (F31.0 - F31.6) diagnosed during the past 12 months by a psychiatrist
- Exclusion Criteria:
- Common between groups (DD, BD, control and GP):
- • Inability to carry out daily monitoring on mobile application for 12 months
- • legal protection measure (guardianship or curatorship)
- For control group:
- • Current diagnosis of psychiatric disorder in ICD-10 (F20-F98) or prescription of psychotropic treatment
- • History of depression (F32)
- • Syndrome of dependence on a psychoactive substance other than tobacco
- • Neurological history (in particular history of stroke, coma, epilepsy, neuro- inflammatory, or neuro-degenerative disease)
- • Inability to carry out daily monitoring on mobile application for 12 months
- • For patients and healthy volunteers for whom an MRI (without injection of contrast agent) is proposed
- • Contraindication to MRI: cardiac pacemaker not compatible with MRI, heart valve implant, implant or metallic foreign body
- • Pregnant woman (at the time of MRI)
About Centre Hospitalier St Anne
Centre Hospitalier St. Anne is a leading healthcare institution dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical research. With a strong emphasis on mental health and neurology, the center is committed to conducting high-quality clinical trials that adhere to rigorous ethical standards and regulatory guidelines. By fostering collaboration among multidisciplinary teams of experienced researchers and healthcare professionals, Centre Hospitalier St. Anne aims to contribute to the development of new therapies and treatment modalities, ultimately enhancing the quality of care for patients in both local and global contexts.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Paris, , France
Patients applied
Trial Officials
Fabien Vinckier, Dr
Principal Investigator
GHU Paris Psychiatry & Neurosciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported